Micro Vascular Dysfunction and its Impact on Neurological Disorders

Sierra Baker^*
*Correspondence: Sierra Baker, Department of Anatomy, Histology, Forensic-Medicine and Orthopedics, University of Rome, Rome, Italy, Email:

Keywords

Neurological disorders • Positron emission tomography • Magnetic resonance imaging

Introduction

Micro vascular dysfunction encompasses a wide range of pathophysiological changes that occur within the small blood vessels, including arterioles, capillaries and venules. While it has been extensively studied in the context of cardiovascular diseases, emerging evidence suggests that micro vascular dysfunction plays a crucial role in the pathogenesis and progression of neurological disorders. This review aims to provide an in-depth exploration of the complex relationship between micro vascular dysfunction and neurological disorders, with a focus on its underlying mechanisms, diagnostic approaches, and potential therapeutic strategies [1].

Literature Review

The Blood-Brain Barrier (BBB) is a specialized micro vascular structure that regulates the passage of molecules and cells between the bloodstream and the brain parenchyma. Micro vascular dysfunction can compromise BBB integrity through various mechanisms, such as oxidative stress, inflammation and endothelial dysfunction. This disruption allows the infiltration of neurotoxic substances, immune cells and pathogens into the brain, contributing to neuroinflammation and neurodegeneration. Adequate Cerebral Blood Flow (CBF) is essential for maintaining neuronal function and homeostasis. Micro vascular dysfunction can impair CBF regulation, leading to cerebral hypo perfusion or hyper perfusion, both of which are detrimental to neurological health. Dysfunctional regulation of CBF is implicated in conditions like ischemic stroke, vascular dementia, and neurovascular coupling disorders. Micro vascular dysfunction can trigger and perpetuate neuroinflammatory responses. Endothelial dysfunction in the brain's microvasculature can lead to the activation of astrocytes and microglia, resulting in the release of proinflammatory cytokines and chemokines. Chronic neuroinflammation is a common feature in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease [2,3].

Discussion

Oxidative stress is a hallmark of many neurological disorders. Micro vascular dysfunction can contribute to oxidative stress through the generation of Reactive Oxygen Species (ROS) and impaired antioxidant defence mechanisms. Oxidative stress, in turn, exacerbates endothelial dysfunction and promotes neurodegeneration various imaging techniques, including Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and cerebral angiography, can be used to assess micro vascular function in the brain. These methods allow for the visualization of CBF, BBB permeability and micro vascular structure. Advanced imaging approaches, such as functional MRI (fMRI) and dynamic contrast-enhanced MRI, provide insights into neurovascular coupling and BBB integrity [4].

Various imaging techniques, including Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) and cerebral angiography, can be used to assess micro vascular function in the brain. These methods allow for the visualization of CBF, BBB permeability and micro vascular structure. Advanced imaging approaches, such as functional MRI (fMRI) and dynamic contrast-enhanced MRI, provide insights into neurovascular coupling and BBB integrity. Analysis of Cerebrospinal Fluid (CSF) biomarkers can provide valuable information about micro vascular dysfunction in neurological disorders. Biomarkers such as Matrix Metalloproteinase (MMPs), Vascular Endothelial Growth Factor (VEGF), and soluble adhesion molecules reflect endothelial activation and BBB disruption. Specific neuroimaging markers, such as White Matter Hyper intensities (WMHs) and cerebral micro bleeds are associated with micro vascular dysfunction-related pathologies. These markers can aid in the diagnosis and monitoring of conditions like Cerebral Small Vessel Disease (CSVD) [5,6].

Conclusion

Micro vascular dysfunction is emerging as a critical player in the pathophysiology of various neurological disorders. Understanding the underlying mechanisms, diagnostic approaches, and potential therapeutic strategies is crucial for developing effective treatments and improving outcomes for individuals affected by these conditions. Further research is needed to unravel the intricacies of micro vascular dysfunction in neurological disorders and translate these insights into clinical practice. Addressing micro vascular dysfunction may open new avenues for preventing, diagnosing, and treating a wide range of neurological disorders, ultimately enhancing the quality of life for affected individuals.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Dhawan, Rahul, Rebekah L. Gundry, David M. Brett-Major and Claudius Mahr, et al. "COVID-19 and cardiovascular disease: What we know, what we think we know and what we need to know." J Mol Cell Cardiol 144 (2020): 12.

Google Scholar, Crossref, Indexed at

2. Ma, Zhangjing, Kevin Y. Yang, Yu Huang and Kathy O. Lui. "Endothelial contribution to COVID-19: An update on mechanisms and therapeutic implications." J Mol Cell Cardiol 164 (2022): 69-82.

Google Scholar, Crossref, Indexed at

3. Kutryb-Zajac, Barbara, Ada Kawecka, Fiona Caratis and Krzysztof Urbanowicz, et al. "The impaired distribution of adenosine deaminase isoenzymes in multiple sclerosis plasma and cerebrospinal fluid."       Front Mol Neurosci 15 (2022): 998023.

Google Scholar, Crossref, Indexed at

4. Grenz, Almut, Dirk Homann and Holger K. Eltzschig. "Extracellular adenosine: A safety signal that dampens hypoxia-induced inflammation during ischemia." Antioxid Redox Signal 15 (2011): 2221-2234.

Google Scholar, Crossref, Indexed at

5. Wu, Zhijie, Shouguo Gao, Naoki Watanabe and Sai Batchu, et al. "Single-cell profiling of T lymphocytes in deficiency of adenosine deaminase 2." J Leukoc Biol 111 (2022): 301-312.

Google Scholar, Crossref, Indexed at

6. Hasan, Amal, Ebaa Al-Ozairi, Zahraa Al-Baqsumi and Rasheed Ahmad, et al. "Cellular and humoral immune responses in covid-19 and immunotherapeutic approaches." Immuno Targets Ther (2021): 63-85.

Google Scholar, Crossref, Indexed at